United States · FDA National Drug Code directory
daptomycin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 14335-120_0a1a4553-120c-b67d-e063-6294a90a0572
- Product NDC
- 14335-120
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
- Composition / generic term
- daptomycin
- Labeler
- Hainan Poly Pharm., Co., Ltd.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20231114
- Source listing expiry
- 20261231
Source-listed ingredients
- DAPTOMYCIN — 500 mg/20mL
These values do not establish equivalence or a dose recommendation.
Packages
- 20 mL in 1 VIAL, SINGLE-DOSE (14335-120-01) · 14335-120-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →